A Study to Assess the Experimental Malaria Vaccines RH5.2-VLP and R21
NCT05357560
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
107
Enrollment
OTHER
Sponsor class
Conditions
Malaria, Plasmodium Falciparum
Interventions
BIOLOGICAL:
Matrix-M with RH5.2 VLP and/or R21
Sponsor
University of Oxford
Collaborators
[object Object]
[object Object]